Type here to filter the list

Thursday, May 29th
9:30 AM - 10:30 AM East Coast USA Time
Transformative Advancements in the Treatment of Immune-Mediated Diseases: Integrating Patient-Centric Clinical Pharmacology with Translational MID3 for Biologics
Location: National Harbor 3
Chair: Sihem Bihorel, PharmD, PhD (she/her/hers) – Merck & Co.
Chair: Li Zhang, PhD (she/her/hers) – Daiichi Sankyo
Speaker: Li Zhang, PhD (she/her/hers) – Daiichi Sankyo
Speaker: Dipak Pisal, PhD – US Food and Drug Administration
Speaker: Sihem Bihorel, PharmD, PhD (she/her/hers) – Merck & Co.
Moderator: Brian Cicali, PhD – University of Florida
Biologics (BIO)Translational Informatics (TI)
Friday, May 30th
11:00 AM - 12:00 PM East Coast USA Time
Optimizing Dose Selection for Bispecifics: Lessons Learned
Location: National Harbor 3
Chair: Ahmed A. Othman, PhD – Exelixis, Inc.
Chair: Mohamed-Eslam Mohamed, PhD, RPh – AbbVie
Speaker: Priyanka Madia, PhD – Gilead Sciences
Speaker: Jason H. Williams, PhD – Exelixis
Speaker: Tommy R. Li, PhD – Genmab
Oncology (ONC)Biologics (BIO)